Last news
EBC Financial Group Recognised as Best Broker for Execution at Professional Trader Awards 2025

EBC Financial Group Recognised as Best Broker for Execution at Professional Trader Awards 2025

Notified -...

Private Healthcare Costs Are Rewriting the Map for Migrating Millionaires, New Data Shows

Private Healthcare Costs Are Rewriting the Map for Migrating Millionaires, New Data Shows

Notified -...

SHELL PLC THIRD QUARTER 2025 EURO AND GBP EQUIVALENT DIVIDEND PAYMENTS

SHELL PLC THIRD QUARTER 2025 EURO AND GBP EQUIVALENT DIVIDEND PAYMENTS

Notified -...

NOTICE TO DISREGARD -- ICARO Media Group

NOTICE TO DISREGARD -- ICARO Media Group

Notified -...

Digital Realty Announces Access to Oracle Cloud Infrastructure in Singapore via FastConnect

Digital Realty Announces Access to Oracle Cloud Infrastructure in Singapore via FastConnect

Notified -...

Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting

Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting

Notified -...

CAPHRA Raises Alarm over Legitimacy of WHO Tobacco Treaty.

CAPHRA Raises Alarm over Legitimacy of WHO Tobacco Treaty.

Notified -...

Io Therapeutics presents today at the American Society for Hematology Annual Meeting, preclinical studies demonstrating combination treatment with BCMA CAR-T cells plus the company's RXR agonist compound IRX4204 has synergistic efficacy against human mul

Io Therapeutics presents today at the American Society for Hematology Annual Meeting, preclinical studies demonstrating combination treatment with BCMA CAR-T cells plus the company's RXR agonist compound IRX4204 has synergistic efficacy against human mul

Notified -...

1 ... 7 8 9 10 11 12 13 14 15 ... 972
menu
menu